Elanco Animal Health (ELAN) Tops Q2 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Elanco Animal Health Reports Second Quarter 2022 Results
August 8, 2022 6:30 AM EDTSecond Quarter 2022 Financial Results Revenue of $1,177 million Reported Net Loss of $22 million, Adjusted Net Income of $177 million Adjusted EBITDA of $300 million or 25.5% of Revenue Reported EPS of $(0.04), Adjusted EPS of $0.36 Updating full year 2022 guidance to reflect current assumptions related to economic, environmental and company-specific factors impacting the business, expecting: Revenue of $4,465 to $4,550 million Reported diluted EPS of $(0.10) to $(0.03), Adjusted EPS of $1.06 to $1.13 Reported Net Loss of $(48) to $(15) million, Adjusted... More
